A prospective multicenter study of venous thromboembolism in patients with newly-diagnosed high-grade glioma: hazard rate and risk factors

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neuro-Oncology

• Publication date

  2015-06-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11060-015-1840-zPMID 26100546PMCID PMC4659392
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome.

  2014cited by this paper
• Sex Difference in Risk of Second but Not of First Venous Thrombosis: Paradox Explained

  2014cited by this paper
• Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas.

  2014cited by this paper
• D-dimer plasma level: a reliable marker for venous thromboembolism after elective craniotomy.

  2013cited by this paper
• Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis

  2011cited by this paper
• PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma

  2010cited by this paper
• Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors

  2009cited by this paper
• Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients

  2009cited by this paper
• High Factor VIII Levels Independently Predict Venous Thromboembolism in Cancer Patients: The Cancer and Thrombosis Study

  2009cited by this paper
• Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial

  2008cited by this paper
• Venous thromboembolism and survival in patients with high-grade glioma.

  2007cited by this paper
• Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

  2007cited by this paper
• Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.

  2007cited by this paper
• Predicting adverse outcome in outpatients with acute deep vein thrombosis. findings from the RIETE Registry.

  2006cited by this paper
• Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.

  2006cited by this paper
• Postoperative venous thromboembolism and brain tumors: part III. Biochemical profile

  2004cited by this paper
• ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas

  2004cited by this paper
• Thromboembolism in hospitalized neutropenic cancer patients.

  2004cited by this paper
• Elevated Clotting Factor Levels and Venous Thrombosis

  2003cited by this paper
• Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

  2002cited by this paper
• Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

  2000cited by this paper
• High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.

  2000cited by this paper
• Incidence and risk of thromboembolism during treatment of high-grade gliomas: a prospective study

  1997cited by this paper
• Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study.

  1997cited by this paper
• Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis.

  1995cited by this paper
• Thromboembolism in patients with high-grade glioma.

  1994cited by this paper
• Venous Thromboembolism and High Grade Gliomas

  1993cited by this paper
• Postoperative venous thromboembolism and brain tumors: part I. Clinical profile

  1992cited by this paper
• Postoperative venous thromboembolism and brain tumors: part II. Hemostatic profile

  1992cited by this paper
• The Incidence and significance of thromboembolic complications in patients with high‐grade gliomas

  1991cited by this paper
• Incidence and treatment of peripheral venous thrombosis in patients with glioma

  1983cited by this paper
• Incidence of lower extremity deep vein thrombosis in neurosurgical patients.

  1980cited by this paper
• Thrombosis and intracranial tumors

  1975cited by this paper

• Venous thromboembolism risk factors in pediatric patients with high-grade glioma: a multicenter retrospective study

  2025cites this paper
• Prevalence and risk factors for asymptomatic venous thromboembolism in patients with primary brain tumors

  2025cites this paper
• Comparative efficacy of certoparin, enoxaparin, and combined thromboprophylaxis on thromboembolic events after glioblastoma resection: a prospective observational study

  2025cites this paper
• Thrombin generation assay in venous thromboembolism: A scoping review.

  2025cites this paper
• Venous thromboembolism incidence shortens survival in isocitrate dehydrogenase wild-type glioblastoma

  2025cites this paper
• Glioblastoma Cells Express and Secrete Alternatively Spliced Transcripts of Coagulation Factor X

  2025influential citation
• The incidence of venous thromboembolism by type of solid cancer worldwide: A systematic review.

  2025cites this paper
• Role of matrix metalloproteinases in the invasion of glioblastoma and drug interventions (Review)

  2025cites this paper
• Evidence gap in predicting intracranial haemorrhage risk in people with glioma on anticoagulants: a scoping review

  2025cites this paper
• Intracerebral hemorrhage risk in glioma patients taking direct oral anticoagulants as compared with low molecular weight heparin

  2025cites this paper
• The risk of venous thromboembolism in adult patients with diffuse glioma: a nationwide population-based study

  2024cites this paper
• Clinical Challenges in Treating Cancer-Associated Thrombosis: A Clinically Oriented Review

  2024cites this paper
• Risk of Postoperative Hemorrhage After Glioma Surgery in Patients with Preoperative Acetylsalicylic Acid

  2024cites this paper
• Incidence of venous thromboembolism and bleeding in patients with malignant central nervous system neoplasm: Systematic review and meta-analysis

  2024cites this paper
• Medical and neurologic management of brain tumor patients

  2024cites this paper
• Venous Thromboembolism in Patients with Glioblastoma: Molecular Mechanisms and Clinical Implications

  2024cites this paper
• Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review.

  2023cites this paper
• Relevant pharmacologic interactions in the concurrent management of brain tumor-related epilepsy and venous thromboembolism: a systematic review

  2022influential citation
• Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.

  2022cites this paper
• Venous thromboembolic events in glioblastoma patients: An epidemiological study

  2022cites this paper
• Risk of intracranial hemorrhage with direct oral anticoagulants versus low molecular weight heparin in glioblastoma: A retrospective cohort study.

  2022cites this paper
• A Retrospective Comparative Cohort Study of Craniotomy and Prophylactic Enoxaparin Timing

  2022influential citation
• Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients

  2022cites this paper
• Neutrophil-to-lymphocyte ratio, Factor VIII and Antithrombin III: inflammatory-clotting biomarkers in glioma

  2021cites this paper
• Incidence, and preoperative and intraoperative prognostic factors of deep venous thrombosis in patients with glioma following craniotomy.

  2021cites this paper
• New Insights in Coagulation and Fibrinolysis in Patients with Primary Brain Cancer: A Systematic Review

  2021cites this paper
• Medical and Neurological Management of Brain Tumor Complications

  2021cites this paper
• Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk

  2021influential citation
• Management of Venous Thromboembolism in High-Grade Glioma: Does Low Molecular Weight Heparin Increase Intracranial Bleeding Risk?

  2021cites this paper
• Approach to the high-grade glioma patient

  2021cites this paper
• IDH mutation status and the development of venous thromboembolism in astrocytoma patients.

  2021cites this paper
• Unfractionated Heparin TID Dosing Regimen is Associated with a Lower Rate of Pulmonary Embolism when Compared to BID Dosing in Patients Undergoing Craniotomy.

  2021cites this paper
• Safety of apixaban for venous thromboembolic primary prophylaxis in patients with newly diagnosed malignant glioma

  2021cites this paper
• Risk of Thromboembolic Disease and Hemorrhage in Patients with Multiform Glioblastoma

  2021cites this paper
• A Hematological-Related Prognostic Scoring System for Patients With Newly Diagnosed Glioblastoma

  2020cites this paper
• A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place

  2020cites this paper
• Incidence, Therapy, and Bleeding Risk—Cancer- Associated Thrombosis in Patients with Glioblastoma

  2020influential citation
• microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors

  2020cites this paper
• Venous Thromboembolism in Patients With Brain Cancer: Focus on Prophylaxis and Management

  2020cites this paper
• Benign and malignant tumors of the central nervous system and pregnancy.

  2020cites this paper
• Impaired contraction of blood clots precedes and predicts postoperative venous thromboembolism

  2020cites this paper
• Risk of Venous Thromboembolism in Grade II–IV Gliomas as a Function of Molecular Subtype

  2020cites this paper
• Thromboprophylaxis in Neuro Intensive Care Unit

  2019cites this paper
• Significance and Prognostic Value of The Coagulation Profile in Patients with Glioblastoma: Implications for Personalized Therapy.

  2019cites this paper
• Venous Thromboembolism in Brain Tumors: Risk Factors, Molecular Mechanisms, and Clinical Challenges

  2019cites this paper
• The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma

  2019cites this paper
• Clinical Concepts of Brain Tumors

  2019cites this paper
• Incidence of Dural Venous Sinus Thrombosis in Patients with Glioblastoma and Its Implications.

  2019cites this paper
• Evaluation of a D-dimer Protocol for Detection of Venous Thromboembolism.

  2019cites this paper
• Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?

  2018cites this paper
• The clinical relevance of ABO blood type in 100 patients with acute subdural hematoma

  2018cites this paper
• Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling.

  2018cites this paper
• Neurologic and Medical Management of Brain Tumors.

  2018cites this paper
• Effects of miRNA-130a on the proliferation and apoptosis of glioma cell lines

  2018cites this paper
• Systematic Review of Safety and Cost‐Effectiveness of Venous Thromboembolism Prophylaxis Strategies in Patients Undergoing Craniotomy for Brain Tumor

  2018cites this paper
• Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients

  2018cites this paper
• Changing Paradigms in the Rehabilitation of Inpatients with Brain Tumors

  2018cites this paper
• Quality improvement in neurology

  2018cites this paper
• Quality improvement in neurology

  2018cites this paper
• Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.

  2018cites this paper
• Length of Thromboprophylaxis in Patients Operated on for a High-Grade Glioma: A Retrospective Study.

  2018cites this paper
• Influence of ABO blood type on the outcome after non-aneurysmal subarachnoid hemorrhage

  2018cites this paper
• Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis

  2017cites this paper
• A pilot study on the applicability of thromboelastometry in detecting brain tumour-induced hypercoagulation

  2017cites this paper
• Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

  2017cites this paper
• Medical Complications of Brain Tumors

  2017cites this paper
• Thromboprophylaxis in Cancer Patients Undergoing Surgery

  2017cites this paper
• European guidelines on perioperative venous thromboembolism prophylaxis: Neurosurgery.

  2017cites this paper
• [Some features controlling the blood D-dimer level after resection of malignant brain glioma].

  2017cites this paper
• Increased risk of venous thromboembolism in patients with brain tumors: A systematic review and meta-analysis.

  2016cites this paper
• Caring for Patients with Newly Diagnosed High-Grade Gliomas

  2016cites this paper
• Recurrent venous thromboembolism in glioblastoma.

  2016cites this paper
• [Risk of venous thromboembolism in cancer patients: Reality, actuality and perspectives].

  2016cites this paper
• Decision-making in a patient with cardiac arrest due to venous thromboembolism within 24 h after glioblastoma resection

  2016cites this paper